The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Maxime Dougados

Rene Descartes University

Medicine Faculty

Hospital Cochin

Rheumatology B Department

France

[email]@cch.ap-hop-paris.fr

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Rene Descartes University, Medicine Faculty, Hospital Cochin, Rheumatology B Department, France. 2001 - 2010
  • Hopital Cochin, Descartes University, Service de Rhumatologie B, Paris, France. 2007
  • Hôpital Cochin, René Descartes University, 27, Rue du Faubourg Saint-Jacques, 75679 Paris Cedex 14, France. 2005
  • Université René Descartes and Hôpital Cochin, Paris, France. 1999 - 2004
  • Service de Rhumatologie, Hôpital Cochin, 27 Rue du Faubourg St-Jacques, Paris 75014, France. 2004
  • Clinique de Rhumatologie B Groupe, Hospitalier Cochin, Paris, France. 2004
  • Centre Hospitalier Universitaire Dijon, and INSERM/ERIT-M 0207, University of Burgundy, Dijon, France. 2003

References

  1. Evaluation of disease activity assessments in patients with rheumatoid arthritis and an inadequate response to anti-TNF therapy: analyses of abatacept clinical trial data. Dougados, M., Wells, G., Schmidely, N., Le Bars, M., van Riel, P., Aletaha, D., Schiff, M., Smolen, J. Clin. Exp. Rheumatol. (2010) [Pubmed]
  2. Evaluation of different methods used to assess disease activity in rheumatoid arthritis: analyses of abatacept clinical trial data. Dougados, M., Schmidely, N., Le Bars, M., Lafosse, C., Schiff, M., Smolen, J.S., Aletaha, D., van Riel, P., Wells, G. Ann. Rheum. Dis. (2009) [Pubmed]
  3. Disease activity measures for rheumatoid arthritis. Dougados, M., Aletaha, D., van Riel, P. Clin. Exp. Rheumatol. (2007) [Pubmed]
  4. When a DMARD fails, should patients switch to sulfasalazine or add sulfasalazine to continuing leflunomide?. Dougados, M., Emery, P., Lemmel, E.M., Zerbini, C.A., Brin, S., van Riel, P. Ann. Rheum. Dis. (2005) [Pubmed]
  5. How can one develop disease-modifying drugs in osteoarthritis?. Dougados, M. Curr. Rheumatol. Rep (2005) [Pubmed]
  6. Monitoring osteoarthritis progression and therapy. Dougados, M. Osteoarthr. Cartil. (2004) [Pubmed]
  7. Outcome measures for clinical trials of disease modifying osteoarthritis drugs in patients with hip osteoarthritis. Dougados, M. J. Rheumatol. Suppl (2004) [Pubmed]
  8. EULAR standardised operating procedures for the elaboration, evaluation, dissemination, and implementation of recommendations endorsed by the EULAR standing committees. Dougados, M., Betteridge, N., Burmester, G.R., Euller-Ziegler, L., Guillemin, F., Hirvonen, J., Lloyd, J., Ozen, S., Da Silva, J.A., Emery, P., Kalden, J.R., Kvien, T., Matucci-Cerinic, M., Smolen, J. Ann. Rheum. Dis. (2004) [Pubmed]
  9. The use of glucosamine therapy in osteoarthritis. Zerkak, D., Dougados, M. Curr. Pain. Headache. Rep (2004) [Pubmed]
  10. Long term structural effects of combination therapy in patients with early rheumatoid arthritis: five year follow up of a prospective double blind controlled study. Maillefert, J.F., Combe, B., Goupille, P., Cantagrel, A., Dougados, M. Ann. Rheum. Dis. (2003) [Pubmed]
  11. Conventional treatments for ankylosing spondylitis. Dougados, M., Dijkmans, B., Khan, M., Maksymowych, W., van der Linden, S., Brandt, J. Ann. Rheum. Dis. (2002) [Pubmed]
  12. Why is the concept of spondyloarthropathies important?. Dougados, M., Hochberg, M.C. Best. Pract. Res. Clin. Rheumatol (2002) [Pubmed]
  13. The role of anti-inflammatory drugs in the treatment of osteoarthritis: a European viewpoint. Dougados, M. Clin. Exp. Rheumatol. (2001) [Pubmed]
  14. Evaluation of the structure-modifying effects of diacerein in hip osteoarthritis: ECHODIAH, a three-year, placebo-controlled trial. Evaluation of the Chondromodulating Effect of Diacerein in OA of the Hip. Dougados, M., Nguyen, M., Berdah, L., Maziéres, B., Vignon, E., Lequesne, M. Arthritis Rheum. (2001) [Pubmed]
  15. Treatment of spondyloarthropathies. Recent advances and prospects in 2001. Dougados, M. Joint. Bone. Spine (2001) [Pubmed]
  16. Clinical relevance of C-reactive protein in axial involvement of ankylosing spondylitis. Dougados, M., Gueguen, A., Nakache, J.P., Velicitat, P., Zeidler, H., Veys, E., Calin, A. J. Rheumatol. (1999) [Pubmed]
 
WikiGenes - Universities